Gabelli & Co Starts Continucare (CNU) at Buy
More News related to CNU
- Continucare Unable to Present at the Noble Financial Equity Conference
- Fortuna Silver Mines to Acquire Continuum Resources and 100% of San Jose Project, Mexico
- Fortuna Silver Mines to Acquire Continuum Resources and 100% of San Jose Project, Mexico
- Continucare to Present at the Noble Financial Equity Conference
- Gabelli & Co Starts Continucare (CNU) at Buy
Gabelli & Co initiates coverage on Continucare (AMEX: CNU) with a Buy rating and $3.75 target. The firm notes that volume growth has been steady at 1-3% along with 5% price increases to account for inflation. They also expect the company to use their $12 million in FCF in 2008 to acquire medical centers or repurchase shares.
Gabelli also notes the company is led by Phil Frost, who has had much success at Ivax Labs and Whitman Education.
Related Categories
New CoverageStocks Mentioned
-0.07Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
